Independent Researcher, San Vendemiano-Conegliano, 31020 Treviso, Italy.
Department of Medical, Surgical, and Dental Sciences, University of Milan, 20122 Milan, Italy.
Int J Environ Res Public Health. 2023 Jan 31;20(3):2583. doi: 10.3390/ijerph20032583.
Stabilization of dental implants in the sinus region with a bone height below 4 mm gen-erally requires a two-stage sinus floor elevation surgery. To improve this aspect, the aim of this retrospective study was to demonstrate the feasibility of performing a one-stage maxillary sinus augmentation using an innovative self-condensing implant design, even in case of a bone height close to 2 mm. Clinical and radiological outcomes from 54 patients (26 females; 28 males; 69 total implants positioned) were analyzed 3 years post-surgery. The three-dimensional grafts change was evaluated by Cone-Beam Computed Tomography (CBCT) before surgery (T0), immediately after surgery (T1), and 1-year post-surgery (T2). The sinus floor levels measured at the medial (M-W), middle (MD-W), and lateral (L-W) walls reported: M-W of 1.9 ± 2.4 mm (T1) and 1.7 ± 2.6 mm (T2); MD-W of -0.1 ± 2.7 mm (T1) and 0.7 ± 2.4 mm (T2); L-W of 3.1 ± 3.0 mm (T1) and 3.1 ± 3.0 mm (T2); besides a bone crest height (C-F) of 4.6 ± 2.0 mm (T1) and 12.1 ± 1.4 mm (T2). Moreover, after 3 years only 1 implant was lost, and so an implant survival rate of 98.55% was recorded. In conclusion, these results suggest the efficacy of using this implant design for a one-stage sinus lift approach, not only in terms of increased implant survival rate and decreased marginal bone loss, but also for its potential applicability in case of reduced bone height.
在窦腔区域,当骨高度低于 4 毫米时,通常需要进行两阶段窦底提升手术来稳定种植牙。为了改善这一点,本回顾性研究旨在展示使用创新的自凝种植体设计进行单阶段上颌窦增高术的可行性,即使在接近 2 毫米的骨高度的情况下也是如此。对 54 名患者(26 名女性;28 名男性;共植入 69 个种植体)的临床和放射学结果进行了 3 年的随访。通过锥形束 CT(CBCT)在术前(T0)、术后即刻(T1)和术后 1 年(T2)评估三维移植物变化。测量内侧(M-W)、中间(MD-W)和外侧(L-W)壁的窦底水平:M-W 为 1.9±2.4 毫米(T1)和 1.7±2.6 毫米(T2);MD-W 为-0.1±2.7 毫米(T1)和 0.7±2.4 毫米(T2);L-W 为 3.1±3.0 毫米(T1)和 3.1±3.0 毫米(T2);此外,骨嵴高度(C-F)为 4.6±2.0 毫米(T1)和 12.1±1.4 毫米(T2)。此外,3 年后仅 1 个种植体脱落,因此记录的种植体存活率为 98.55%。总之,这些结果表明,使用这种种植体设计进行单阶段窦提升方法是有效的,不仅在提高种植体存活率和减少边缘骨丢失方面,而且在骨高度降低的情况下也具有潜在的适用性。